Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 166

1.

Blood platelet function abnormalities in cirrhotic patients with esophageal varices in relation to the variceal bleeding history.

Rogalski P, Rogalska-Plonska M, Wroblewski E, Kostecka-Roslen I, Dabrowska M, Swidnicka-Siergiejko A, Wasielica-Berger J, Cydzik M, Hirnle T, Dobrzycki S, Flisiak R, Dabrowski A.

Scand J Gastroenterol. 2019 Mar 23:1-8. doi: 10.1080/00365521.2019.1578822. [Epub ahead of print]

PMID:
30907172
2.

Bivalirudin use in acute coronary syndrome patients undergoing percutaneous coronary interventions in Poland: Clinical update from expert group of the Association on Cardiovascular Interventions of the Polish Cardiac Society.

Kołtowski Ł, Legutko J, Filipiak KJ, Dziewierz A, Bartuś S, Buszman P, Buszman P, Ciećwierz D, Dąbrowski M, Dobrzycki S, Gil R, Gorący J, Grygier M, Jaguszewski M, Kochman J, Kubica J, Kuliczkowki W, Lodziński P, Ochała A, Reczuch K, Witkowski A, Wojakowski W, Wójcik J, Dudek D.

Cardiol J. 2019;26(1):1-7. doi: 10.5603/CJ.2019.0029. No abstract available.

3.

Hepcidin - Potential biomarker of contrast-induced acute kidney injury in patients undergoing percutaneous coronary interventions.

Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Koc-Zorawska E, Matuszkiewicz-Rowinska J, Dobrzycki S.

Adv Med Sci. 2019 Feb 25;64(2):211-215. doi: 10.1016/j.advms.2018.12.008. [Epub ahead of print]

PMID:
30818219
4.

Vitamin D deficiency and anemia is highly prevalent and dependent on the etiology of heart failure: A pilot study.

Małyszko J, Tomaszuk-Kazberuk A, Dobrzycki K, Bachórzewska-Gajewska H, Zorawski M, Koc-Zorawska E, Kobus G, Dobrzycki S.

Cardiol J. 2019 Jan 30. doi: 10.5603/CJ.a2019.0003. [Epub ahead of print]

5.

Patients with Atrial Fibrillation and Chronic Kidney Disease More Often Undergo Angioplasty of Left Main Coronary Artery - a 867 Patient Study.

Tomaszuk-Kazberuk A, Nikas D, Lopatowska P, Młodawska E, Malyszko J, Bachorzewska-Gajewska H, Dobrzycki S, Sobkowicz B, Goudevenos I.

Kidney Blood Press Res. 2018;43(6):1796-1805. doi: 10.1159/000495637. Epub 2018 Nov 30.

6.

Rotational atherectomy in everyday clinical practice. Association of Cardiovascular Interventions of the Polish Society of Cardiology (Asocjacja Interwencji Sercowo-Naczyniowych Polskiego Towarzystwa Kardiologicznego - AISN PTK): Expert opinion.

Dobrzycki S, Reczuch K, Legutko J, Pawłowski T, Grygier M, Ochała A, Wójcik J, Buszman P, Dudek D, Gąsior M, Gil R, Lesiak M, Kukuła K, Witkowski A, Zajdel W, Kralisz P, Wojakowski W, Bartuś S.

Kardiol Pol. 2018;76(11):1576-1584. doi: 10.5603/KP.2018.0225.

7.

Sudden cardiac arrest in the course of takotsubo syndrome in a 15-year-old girl.

Zalewska-Adamiec M, Bachórzewska-Gajewska H, Kralisz P, Tałałaj M, Pryzmont M, Dobrzycki S.

Postepy Kardiol Interwencyjnej. 2018;14(3):318-319. doi: 10.5114/aic.2018.78341. Epub 2018 Sep 21. No abstract available.

8.

Mehran in-stent restenosis classification adapted for coronary bifurcations: the impact on 4-year follow-up from randomized clinical studies POLBOS I and II.

Bil J, Gil RJ, Kern A, Inigo-Garcia LA, Formuszewicz R, Dobrzycki S.

Postepy Kardiol Interwencyjnej. 2018;14(3):299-303. doi: 10.5114/aic.2018.78335. Epub 2018 Sep 21. No abstract available.

9.

Takotsubo syndrome and chronic kidney disease: a deadly duet in long-term follow-up.

Zalewska-Adamiec M, Małyszko J, Bachórzewska-Gajewska H, Tomaszuk-Kazberuk A, Kożuch M, Kralisz P, Dobrzycki S.

Pol Arch Intern Med. 2018 Sep 28;128(9):518-523. doi: 10.20452/pamw.4309. Epub 2018 Jul 27.

10.

Circulating miR-30a-5p as a prognostic biomarker of left ventricular dysfunction after acute myocardial infarction.

Maciejak A, Kostarska-Srokosz E, Gierlak W, Dluzniewski M, Kuch M, Marchel M, Opolski G, Kiliszek M, Matlak K, Dobrzycki S, Lukasik A, Segiet A, Sygitowicz G, Sitkiewicz D, Gora M, Burzynska B.

Sci Rep. 2018 Jun 29;8(1):9883. doi: 10.1038/s41598-018-28118-1.

11.

Regular drug-eluting stents versus dedicated bifurcation drug-eluting BiOSS® stents for coronary bifurcation treatment: four-year results of randomized POLBOS I and POLBOS II clinical trials.

Gil RJ, Bil J, Kern A, Ingio Garcia LA, Formuszewicz R, Dobrzycki S, Vassilev D, Segiet A.

EuroIntervention. 2018 May 8. pii: EIJ-D-18-00172. doi: 10.4244/EIJ-D-18-00172. [Epub ahead of print]

12.

Treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams: Focus on antiplatelet therapies. Updated experts' standpoint.

Kubica J, Adamski P, Paciorek P, Ładny JR, Kalarus Z, Banasiak W, Kochman W, Gorący J, Wożakowska-Kapłon B, Navarese EP, Kleinrok A, Gil R, Lesiak M, Drożdż J, Kubica A, Filipiak KJ, Kaźmierczak J, Goch A, Grajek S, Basiński A, Szarpak Ł, Grześk G, Hoffman P, Wojakowski W, Gąsior Z, Dobrzycki S, Siller-Matula JM, Witkowski A, Kuliczkowski W, Gruchała M, Timler D, Opolski G, Dudek D, Legutko J, Zielińska M, Wójcik J.

Cardiol J. 2018;25(3):291-300. doi: 10.5603/CJ.a2018.0042. Epub 2018 Apr 19. Review.

13.

Perioperative thrombocytopenia predicts poor outcome in patients undergoing transcatheter aortic valve implantation.

Mitrosz M, Kazimierczyk R, Chlabicz M, Sobkowicz B, Waszkiewicz E, Lisowska A, Dobrzycki S, Musial WJ, Hirnle T, Kaminski KA, Tycinska AM.

Adv Med Sci. 2018 Mar;63(1):179-184. doi: 10.1016/j.advms.2017.11.001. Epub 2017 Nov 13.

PMID:
29145170
14.

Transcatheter aortic valve implantation. Expert Consensus of the Association of Cardiovascular Interventions of the Polish Cardiac Society and the Polish Society of Cardio-Thoracic Surgeons, approved by the Board of the Polish Cardiac Society….

Parma R, Zembala MO, Dąbrowski M, Jagielak D, Witkowski A, Suwalski P, Dudek D, Olszówka P, Wojakowski W, Przybylski R, Gil R, Kuśmierczyk M, Lesiak M, Sadowski J, Dobrzycki S, Ochała A, Hoffman P, Kapelak B, Kaźmierczak J, Jasiński M, Stępińska J, Szymański P, Hryniewiecki T, Kochman J, Grygier M, Zembala M, Legutko J, Różański J.

Kardiol Pol. 2017;75(9):937-964. doi: 10.5603/KP.2017.0175.

PMID:
28895996
15.

Comparison of dedicated BIOSS bifurcation stents with regular drug-eluting stents for coronary artery bifurcated lesions: Pooled analysis from two randomized studies.

Gil RJ, Bil J, Kern A, Iñigo Garcia LA, Formuszewicz R, Dobrzycki S, Vassilev D, Segiet A.

Cardiol J. 2018;25(3):308-316. doi: 10.5603/CJ.a2017.0098. Epub 2017 Aug 25.

16.

[Bioresorbable scaffolds in the treatment of coronary artery disease. Expert consensus statement of the Association of Cardiovascular Interventions of the Polish Cardiac Society (ACVI PCS)].

Reczuch K, Milewski K, Wąsek W, Rzeszutko Ł, Wojakowski W, Hawranek M, Włodarczak A, Pawłowski T, Kochman J, Dobrzycki S, Grygier M, Ochała A, Wójcik J, Lesiak M, Dudek D, Legutko J.

Kardiol Pol. 2017;75(8):817-835. doi: 10.5603/KP.2017.0160. Polish.

PMID:
28819961
17.

The causes of thrombocytopenia after transcatheter aortic valve implantation.

Mitrosz M, Kazimierczyk R, Sobkowicz B, Waszkiewicz E, Kralisz P, Frank M, Piszcz J, Galar M, Dobrzycki S, Musial WJ, Hirnle T, Kaminski KA, Tycinska AM.

Thromb Res. 2017 Aug;156:39-44. doi: 10.1016/j.thromres.2017.05.020. Epub 2017 May 26.

PMID:
28582640
18.

Thrombocytopenia associated with TAVI-The summary of possible causes.

Mitrosz M, Chlabicz M, Hapaniuk K, Kaminski KA, Sobkowicz B, Piszcz J, Dobrzycki S, Musial WJ, Hirnle T, Tycinska AM.

Adv Med Sci. 2017 Sep;62(2):378-382. doi: 10.1016/j.advms.2017.04.003. Epub 2017 May 25. Review.

PMID:
28550795
19.

Anti-aggregation therapy in patients with acute coronary syndrome - recommendations for medical emergency teams. Experts' standpoint.

Kubica J, Adamski P, Paciorek P, Ładny JR, Kalarus Z, Banasiak W, Kochman W, Gorący J, Wożakowska-Kapłon B, Navarese EP, Kleinrok A, Gil R, Lesiak M, Drożdż J, Kubica A, Filipiak KJ, Kaźmierczak J, Goch A, Grajek S, Basiński A, Szarpak Ł, Grześk G, Hoffman P, Wojakowski W, Gąsior Z, Dobrzycki S, Siller-Matula JM, Witkowski A, Kuliczkowski W, Gruchała M, Timler D, Opolski G, Dudek D, Legutko J, Zielińska M, Wójcik J.

Kardiol Pol. 2017;75(4):399-408. doi: 10.5603/KP.a2017.0057. No abstract available.

PMID:
28421594
20.

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.

Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators.

J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055.

Supplemental Content

Loading ...
Support Center